501 related articles for article (PubMed ID: 12421226)
41. [Discovery of a chronic HVC infection without seroconversion in a blood donor in France during 28 months].
Durand F; Danic B; Tardivel R; Semana G; Gouezec H; Martinot M; Marcellin P; Beauplet A
Transfus Clin Biol; 2000 Jun; 7(3):242-50. PubMed ID: 10919211
[TBL] [Abstract][Full Text] [Related]
42. Long-term follow-up of and infectivity in blood donors with hepatitis C antibodies and persistently normal alanine aminotransferase levels.
Rossini A; Gazzola GB; Ravaggi A; Agostinelli E; Biasi L; Albertini A; Radaeli E; Cariani E
Transfusion; 1995 Feb; 35(2):108-11. PubMed ID: 7529954
[TBL] [Abstract][Full Text] [Related]
43. Development of low cost peptide-based anti-hepatitis C virus screening and confirmatory assays: comparison with commercially available tests.
Palacios A; Taylor L; Haue L; Luftig RB; Visoná KA
J Med Virol; 1999 Jul; 58(3):221-6. PubMed ID: 10447416
[TBL] [Abstract][Full Text] [Related]
44. Performance of second- and third-generation RIBAs for confirmation of third-generation HCV EIA-reactive blood donations. Retrovirus Epidemiology Donor Study.
Tobler LH; Lee SR; Stramer SL; Peterson J; Kochesky R; Watanabe K; Quan S; Polito A; Busch MP
Transfusion; 2000 Aug; 40(8):917-23. PubMed ID: 10960517
[TBL] [Abstract][Full Text] [Related]
45. Significance of the signal-to-cutoff ratios of anti-hepatitis C virus enzyme immunoassays in screening of Chinese blood donors.
Ren FR; Lv QS; Zhuang H; Li JJ; Gong XY; Gao GJ; Liu CL; Wang JX; Yao FZ; Zheng YR; Zhu FM; Tiemuer MH; Bai XH; Shan H
Transfusion; 2005 Nov; 45(11):1816-22. PubMed ID: 16271110
[TBL] [Abstract][Full Text] [Related]
46. Nucleic acid testing in blood donations reactive to hepatitis C virus antibody, but with an extremely low viral load.
Laperche S; Bouchardeau F; Maniez M; Béolet M; Elghouzzi MH; Lefrère JJ
Vox Sang; 2004 Apr; 86(3):198. PubMed ID: 15078255
[No Abstract] [Full Text] [Related]
47. Evidence that use of a second-generation hepatitis C antibody assay prevents additional cases of transfusion-transmitted hepatitis.
Aoki SK; Kuramoto IK; Anderson S; Schoening V; Rodriguez R; Fernando L; Sazama K; Holland PV
J Viral Hepat; 1994; 1(1):73-7. PubMed ID: 8790562
[TBL] [Abstract][Full Text] [Related]
48. An easy dipstick assay for anti-core antibodies to screen blood donors for hepatitis C virus viremia.
Mulyanto ; Suwignyo S; Tsauri S; Itoh K; Mizui M; Tsuda F; Okamoto H; Yoshizawa H; Mishiro S
Vox Sang; 1996; 70(4):229-31. PubMed ID: 9123929
[No Abstract] [Full Text] [Related]
49. Yield of HCV and HIV-1 NAT after screening of 3.6 million blood donations in central Europe.
Roth WK; Weber M; Buhr S; Drosten C; Weichert W; Sireis W; Hedges D; Seifried E
Transfusion; 2002 Jul; 42(7):862-8. PubMed ID: 12375658
[TBL] [Abstract][Full Text] [Related]
50. Acute nosocomial HCV infection detected by NAT of a regular blood donor.
Larke B; Hu YW; Krajden M; Scalia V; Byrne SK; Boychuk LR; Klein J
Transfusion; 2002 Jun; 42(6):759-65. PubMed ID: 12147030
[TBL] [Abstract][Full Text] [Related]
51. Evaluation of the available anti-HCV antibody detection tests and RT-PCR assay in the diagnosis of hepatitis C virus infection.
Tashkandy MA; Khodari YA; Ibrahim AM; Dhafar KO; Gazzaz ZJ; Azab BA
Saudi J Kidney Dis Transpl; 2007 Nov; 18(4):523-31. PubMed ID: 17951937
[TBL] [Abstract][Full Text] [Related]
52. Hepatitis C virus seroconversion rate in established blood donors.
Atrah HI; Hutchinson F; Gough D; Ala FA; Ahmed MM
J Med Virol; 1995 Aug; 46(4):329-33. PubMed ID: 7595409
[TBL] [Abstract][Full Text] [Related]
53. Hepatitis C virus infection in Spanish volunteer blood donors: HCV RNA analysis and liver disease.
Muñoz-Gómez R; García-Monzón C; García-Buey L; Lo Iacono O; Borque MJ; Garía-Sánchez A; Pajares JM; Moreno-Otero R
Eur J Gastroenterol Hepatol; 1996 Mar; 8(3):273-7. PubMed ID: 8724030
[TBL] [Abstract][Full Text] [Related]
54. Evaluation of NucliSens-AmpliScreen methodology to detect subtypes G of HIV-1 and 4c/4d of HCV in the screening of blood donors.
Araújo F; Henriques I; Monteiro F; Meireles E; Cruz A; Tavares G; Mota-Miranda A
Transfus Clin Biol; 2005 Oct; 12(4):331-5. PubMed ID: 16182583
[TBL] [Abstract][Full Text] [Related]
55. Limited utility of alanine aminotransferase screening of hepatitis C antibody-screened blood donors.
Cable R; Badon S; Pray C; Popovsky MA
Transfusion; 1997 Feb; 37(2):206-10. PubMed ID: 9051097
[TBL] [Abstract][Full Text] [Related]
56. Hepatitis C virus seroconversion by a third generation ELISA screening test in blood donors.
Atrah HI; Ahmed MM
J Clin Pathol; 1996 Mar; 49(3):254-5. PubMed ID: 8675740
[TBL] [Abstract][Full Text] [Related]
57. Frequency of hepatitis C viral RNA in anti-hepatitis C virus non- reactive blood donors with raised alanine aminotransferase.
Ali N; Ahmed SA; Moinuddin ; Hoch SF; Chotani RA
J Coll Physicians Surg Pak; 2011 Dec; 21(12):782-3. PubMed ID: 22166707
[TBL] [Abstract][Full Text] [Related]
58. Prospective study of the meaning of indeterminate results of the recombinant immunoblot assay for hepatitis C virus in blood donors.
Piro L; Solinas S; Luciani M; Casale A; Bighiani T; Santonocito D; Girelli G
Blood Transfus; 2008 Apr; 6(2):107-11. PubMed ID: 18946955
[TBL] [Abstract][Full Text] [Related]
59. Testing of individual blood donations for HCV RNA reduces the residual risk of transfusion-transmitted HCV infection.
Legler TJ; Riggert J; Simson G; Wolf C; Humpe A; Munzel U; Uy A; Köhler M; Heermann KH
Transfusion; 2000 Oct; 40(10):1192-7. PubMed ID: 11061854
[TBL] [Abstract][Full Text] [Related]
60. Predictive value of screening tests for persistent hepatitis C virus infection evidenced by viraemia. Japanese experience.
Watanabe J; Matsumoto C; Fujimura K; Shimada T; Yoshizawa H; Okamoto H; Iizuka H; Tango T; Ikeda H; Endo N
Vox Sang; 1993; 65(3):199-203. PubMed ID: 7504373
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
